RxDoctor Payments Data
★ My doctorsLook up a doctor →

Thomas Obrien

Pulmonary Disease · Kissimmee, FLNPI 1396700803

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $169,900 of the $200,412 with a category attached, or 84.8%. 40 manufacturers reported payments, led by GSK at 52.7% of the total. Reporting peaked in 2019 at $69,332 and has fallen 99.9% since, to $42 in 2024. Among pulmonary disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$200,412in general payments, 2019–2025

Across 641 payments — averaging $312.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$106K
  • AstraZeneca$88K
  • Actelion Pharmaceuticals US, Inc.$804
  • Grifols USA, LLC$666
  • Boehringer Ingelheim$662
  • Mylan Specialty L.p.$499
  • plus $5K from 34 others
$736,280in research payments, 2019–2025

Across 268 payments — averaging $2747.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$194K
  • Kadmon Corporation LLC$117K
  • Philips North America LLC$107K
  • United Therapeutics Corporation$86K
  • Jazz Pharmaceuticals Inc.$60K
  • GSK$53K
  • plus $120K from 8 others

What the payments were for

  • Consulting fees$6,5003%
  • Speaking & faculty fees$169,90085%
  • Travel & lodging$8,9534%
  • Food & beverage$14,8267%
  • Education$2340%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK146$105,536
AstraZeneca(2 entities)144$87,687
Actelion Pharmaceuticals US, Inc.25$804
Grifols USA, LLC34$666
Boehringer Ingelheim37$662
Mylan Specialty L.p.32$499
Genentech USA, Inc.28$489
Harmony Biosciences LLC16$453
Takeda Pharmaceuticals U.S.A., Inc.21$450
Regeneron Healthcare Solutions, Inc.14$405
Insmed, Inc.8$247
Teva Pharmaceuticals USA, Inc.9$225
Sanofi8$203
Paratek Pharmaceuticals, Inc.5$183
Pulmonx Corporation3$169
Electromed, Inc.35$167
Jazz Pharmaceuticals Inc.10$167
Mallinckrodt Hospital Products Inc.5$164
Inspire Medical Systems, Inc.1$123
Phadia US Inc.2$122
Intuitive Surgical1$121
United Therapeutics Corporation6$118
Inogen, Inc.11$96
Novartis5$90
Sunovion Pharmaceuticals Inc.6$89
Covis Pharma GmbH4$73
Shire North American Group Inc4$66
Mallinckrodt Enterprises LLC4$64
Bayer3$43
AbbVie2$38
Advanced Respiratory, Inc2$32
Circassia Inc.2$24
Genentech, Inc.1$21
Baxter Healthcare1$19
Amgen1$19
Melinta Therapeutics, LLC1$18
Amarin Pharma, Inc.1$17
Shionogi Inc1$16
Fisher & Paykel Healthcare Inc1$14
Biogen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$200,412 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida →

Other pulmonary disease in Kissimmee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →